Latest News - Cencora
Top Corporates Hub
Cencora
Here's Why You Should Hold Cencora Stock in Your Portfolio Now
05.09.2025 13:06
COR gains from strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose risks.
Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
05.09.2025 11:11
Explore Cencoraâs growth strategies, specialty market focus, and financial performance
The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call
13.08.2025 05:34
Cencora’s third quarter results outperformed Wall Street’s expectations on both revenue and adjusted profit, but the market reacted negatively, reflecting investor concerns about slower growth in key areas. Management attributed the quarter’s outcomes to continued strength in U.S. Healthcare Solutions, particularly specialty distribution and higher utilization of pharmaceuticals, including GLP-1 products. However, CEO Robert Mauch and CFO James Cleary acknowledged moderating growth in GLP-1s and
COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update
12.08.2025 07:16
Healthcare distributor Cencora (NYSE:COR) announced better-than-expected revenue in Q2 CY2025, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above analysts’ consensus estimates.
Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend
07.08.2025 00:53
Cencora (COR) recently announced strong third-quarter earnings with sales at $80,664 million and net income rising to $687 million, reflecting significant growth. Despite these robust results, the stock price remained flat over the last quarter. These financial achievements, along with a quarterly dividend declaration of $0.55 per share, indicate Cencora's continued shareholder commitment. Although the broader market fluctuated amidst tariff news and earnings reports from other major firms,...
Cencora’s (NYSE:COR) Q2 Sales Top Estimates
06.08.2025 10:48
Healthcare distributor Cencora (NYSE:COR) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.7% year on year to $80.66 billion. Its non-GAAP profit of $4 per share was 4.2% above analysts’ consensus estimates.
Cencora: Fiscal Q3 Earnings Snapshot
06.08.2025 10:44
CONSHOHOCKEN, Pa. AP) — Cencora, Inc. COR) on Wednesday reported fiscal third-quarter earnings of $687.4 million.
Cencora Reports Fiscal 2025 Third Quarter Results
06.08.2025 10:30
CONSHOHOCKEN, Pa., August 06, 2025--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year to $80.7 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $3.52 for the third quarter of fiscal 2025 compared to $2.42 in the prior year third quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below, incr
Podcasting Impact: Unprecedented Press Coverage of All Three National Drug Wholesaler Conferences Supporting Independent Pharmacy
06.08.2025 09:00
First podcast dedicated to the profession of pharmacy covers McKesson, Cencora, and Cardinal Health events BROWNSVILLE PA / ACCESS Newswire / August 6, 2025 / RxPR, LLC is proud to announce that the Pharmacy Podcast Network (PPN) has successfully ...
Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top
05.08.2025 13:05
HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.
What To Expect From Cencora’s (COR) Q2 Earnings
05.08.2025 03:11
Healthcare distributor Cencora (NYSE:COR) will be announcing earnings results this Wednesday before market open. Here’s what to expect.
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
31.07.2025 15:40
Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
31.07.2025 14:01
CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin gains.
Progyny (PGNY) Earnings Expected to Grow: Should You Buy?
31.07.2025 14:00
Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down
31.07.2025 12:46
Align Technology tumbles 34.2% after Q2 earnings and revenues miss estimates as Clear Aligner sales drop and margins tighten further.
Cencora, Inc. (COR): A Bull Case Theory
24.07.2025 14:25
We came across a bullish thesis on Cencora, Inc. on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on COR. Cencora, Inc.’s share was trading at $292.67 as of July 21st. COR’s trailing and forward P/E were 33.87 and 16.81, respectively according to Yahoo Finance. Cencora, Inc. stands as a critical pillar […]
WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up?
22.07.2025 16:11
West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.
Farmina Pet Foods Expands U.S. Veterinary Presence with National Distribution Agreement with MWI Animal Health
22.07.2025 14:01
Farmina Pet Foods, a global leader in premium pet nutrition, has signed a national distribution agreement with MWI Animal Health (MWI), a leading provider of veterinary solutions and a part of Cencora (formerly AmerisourceBergen). Through this partnership, MWI will market and distribute Farmina's VetLife line of therapeutic diets, increasing access to science-backed, natural pet nutrition for veterinary practices and pet families across the United States.
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises
22.07.2025 12:39
DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.
Good Neighbor Pharmacy Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2025
18.07.2025 16:00
CONSHOHOCKEN, Pa., July 18, 2025--Good Neighbor Pharmacy, a national franchise for independent pharmacies offered through Cencora, brought together more than 4,000 community pharmacy owners, industry experts and partners for its flagship annual tradeshow and conference, ThoughtSpot. Now in its 14th year, ThoughtSpot serves as a celebration of Good Neighbor Pharmacy and its member pharmacies, recognizing their unwavering commitment to improving community health and advancing the future of pharmac